Ginkgo Bioworks Holdings, Inc. (DNA) News

Ginkgo Bioworks Holdings, Inc. (DNA): $1.82

-0.12 (-6.19%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DNA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 399

in industry

Filter DNA News Items

DNA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

DNA News Highlights

  • DNA's 30 day story count now stands at 19.
  • Over the past 23 days, the trend for DNA's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • LYFT, MRNA and XWEL are the most mentioned tickers in articles about DNA.

Latest DNA News From Around the Web

Below are the latest news stories about GINKGO BIOWORKS HOLDINGS INC that investors may wish to consider to help them evaluate DNA as an investment opportunity.

That Will Motivate You Today: Lyft, Inc. (NASDAQ:LYFT 3.66%), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA -2.76%)

LYFT has seen its SMA50 which is now 34.01%. In looking the SMA 200 we see that the stock has seen a -2.22%. DNA has seen its SMA50 which is … The post That Will Motivate You Today: Lyft, Inc. (NASDAQ:LYFT 3.66%), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA -2.76%) appeared first on Stocks Equity .

Stock Equity | January 26, 2023

Stocks in News: Huntington Bancshares Incorporated (NASDAQ:HBAN -0.36%), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA -8.74%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Stocks in News: Huntington Bancshares Incorporated (NASDAQ:HBAN -0.36%), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA -8.74%) appeared first on Stocks Equity .

Stock Equity | January 20, 2023

Two Stocks Disappointing Investors: The Kraft Heinz Company (NASDAQ:KHC -6.31%), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA -8.04%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Two Stocks Disappointing Investors: The Kraft Heinz Company (NASDAQ:KHC -6.31%), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA -8.04%) appeared first on Stocks Equity .

Stock Equity | January 19, 2023

NAMUH and Ginkgo Bioworks Announce Partnership to Produce Multiple Infant Nutrition Products

NAMUH, an infant nutrition company, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a multi-product collaboration to develop functional oligosaccharides that are structurally identical to those found in human breast milk.

Yahoo | January 18, 2023

Ginkgo Bioworks Partners With Ukraine on Wastewater Testing; CDC on Flu Monitoring

The announcements come a week after Ginkgo announced that it would meet its full-year 2022 revenue guidance on the strength of biosecurity revenues.

GenomeWeb | January 17, 2023

Ginkgo Bioworks and XpresCheck Expand CDC’s Traveler-Based Genomic Surveillance Program to Detect Influenza Variants

The program is an effective early warning system for viral variants, leveraging voluntary sampling from international travelers at major U.S. airports BOSTON and NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Ginkgo Bioworks (NYSE: DNA) and XWELL, Inc. (Nasdaq: XWEL) today announced that they have expanded their support for the Centers for Disease Control and Prevention’s (CDC’s) Traveler-based

Wallstreet:Online | January 17, 2023

Ginkgo Bioworks and the Public Health Center of the Ukraine Ministry of Health Announce Collaboration to Implement Biosecurity Capabilities in Ukraine

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and the Public Health Center of the Ukraine Ministry of Health today announced a new collaboration to conduct a wastewater testing pilot program in Ukraine with the intent to help provide early warning for infectious disease outbreaks and enable rapid and strategic public health intervention.

Yahoo | January 17, 2023

3 Penny Stocks That Could Rise 500% in 2023

Tilt the odds in your favor in 2023 with some of these high-potential penny stocks.

Thomas Yeung on InvestorPlace | January 13, 2023

Ginkgo Bioworks: Increasing Focus On Pharma And Biotech

Ginkgo''s Foundry business continues to expand, although the long-term economics remain uncertain. Click here to read my analysis of DNA stock.

Seeking Alpha | January 12, 2023

Ginkgo Bioworks Holdings Insider Trades Send a Signal

Barry Canton , 10% Owner at Ginkgo Bioworks Holdings (NYSE: DNA ), reported a large insider sell on January 10, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Canton sold 608,506 shares of Ginkgo Bioworks Holdings . The total transaction amounted to $915,194. Ginkgo Bioworks Holdings shares are trading up 3.25% at $1.59 at the time of this writing on Wednesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used … Full story available on Benzinga.com

Benzinga | January 11, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5348 seconds.